Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASKC200 in Patients With Knee Osteoarthritis Pain
NCT07742852Phase 2Active, not recruiting
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of CGS-200-5 in knee osteoarthritis (OA), sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Sep 2025; status: active, not recruiting.
02
Drugs
CGS-200-5
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07742852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742852.